NCT06428214View on ClinicalTrials.gov

A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

July 25, 2024

Study Completion Date

September 24, 2024

Conditions
Chin Augmentation
Interventions
DEVICE

Restylane Shaype

Injection

DEVICE

Restylane Defyne

Injection

DEVICE

Restylane Lyft lidocaine

Injection

Trial Locations (3)

V6H 4E1

Galderma Investigational Site # 8754, Vancouver

L7N3N2

Galderma Investigational Site 8379, Burlington

H3Z 1C3

Galderma Investigational Site 8690, Westmount

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT06428214 - A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies | Biotech Hunter | Biotech Hunter